nach oben

Metabolic Brain Disease

Erschienen in:

22.06.2019 | Original Article

The effect of hyperglycinemic treatment in captive-bred Vervet monkeys (Chlorocebus aethiops)

verfasst von: Zandisiwe E. Magwebu, Mikateko Mazinu, Sahar Abdul-Rasool, Chesa G. Chauke

Erschienen in: Metabolic Brain Disease | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Abstract

Nonketotic hyperglycinemia (NKH) is a neuro-metabolic disorder caused by a deficiency in the glycine cleavage system (GCS) and glycine transporter 1 (GlyT1). A case of atypical late onset of NKH has been reported in a colony of captive-bred Vervet monkeys. The purpose of this study was to evaluate the effect of sodium benzoate and dextromethorphan in reducing glycine levels in hyperglycinemic monkeys. Twelve captive-bred Vervet monkeys were assigned into three groups consisting of four animals (control, valproate induced and cataract with spontaneous hyperglycinemia). Valproate was used to elevate glycine levels and the induced group was then treated with sodium benzoate and dextromethorphan together with group three to normalise glycine levels in cerebrospinal fluid (CSF) and plasma. Valproate induction elicited changes in phosphate, alkaline phosphatase and platelet count, however, no significant changes in the glycine levels were observed, and this might be due to the individual variability within the group. The treatment intervention was only obtained in the spontaneous group whereby the glycine levels were normalised in CSF and plasma. Therefore, it can be concluded that sodium benzoate and dextromethorphan treatment was effective and beneficial to the hyperglycinemic group.

Aghebati T, Foroughipour M, Azarpazhooh MR, Mokhber N, Khayat MH, Vahdati N, Mohammadpour AH (2012) Relationship between patient demographic characteristics, Valproic acid dosage and clearance in adult Iranian patients. Iran J Basic Med Sci 15:702PubMedPubMedCentral

Ahmed SN, Siddiqi ZA (2006) Antiepileptic drugs and liver disease. Seizure 15:156–164CrossRefPubMed

Applegarth DA, Toone JR (2006) Glycine encephalopathy (nonketotic hyperglycinemia): comments and speculations. Am J Med Genet A 140:186–188CrossRefPubMed

Arnold G, Griebel M, Valentine J, Koroma D, Kearns G (1997) Dextromethorphan in nonketotic hyperglycinaemia: metabolic variation confounds the dose-response relationship. J Inherit Metab Dis 20:28–38CrossRefPubMed

Bhamkar RP, Colaco P (2007) Neonatal nonketotic hyperglycinemia. Indian J Pediatr 74:1124–1126CrossRefPubMed

Boneh A, Korman SH, Sato K, Kanno J, Matsubara Y, Lerer I, Ben-Neriah Z, Kure S (2005) A single nucleotide substitution that abolishes the initiator methionine codon of the GLDC gene is prevalent among patients with glycine encephalopathy in Jerusalem. J Hum Genet 50:230–234CrossRefPubMed

Chatzistefanidis D, Georgiou I, Kyritsis AP, Markoula S (2012) Functional impact and prevalence of polymorphisms involved in the hepatic glucuronidation of valproic acid. Pharmacogenomics 13:1055–1071CrossRefPubMed

Chauke CG, Magwebu ZE, Sharma JR, Arieff Z, Seier JV (2016) Mutation analysis of GLDC, AMT and GCSH in cataract captive-bred vervet monkeys (Chlorocebus aethiops). J Med Primatol 45:189–194CrossRefPubMed

Churchill A, Graw J (2011) Clinical and experimental advances in congenital and paediatric cataracts. Phil Trans R Soc B 366:1234–1249CrossRefPubMed

De Villiers C, Seier JV, Dhansay MA (2001) Probable genetic origin for a large number of cataracts among captive-bred vervet monkeys (Chlorocebus aethiops). Am J Primatol 55:43–48CrossRefPubMed

Delgado MR, Riela AR, Mills J, Browne R, Roach ES (1994) Thrombocytopenia secondary to high valproate levels in children with epilepsy. J Child Neurol 9:311–314CrossRefPubMed

Dinopoulos A, Matsubara Y, Kure S (2005) Atypical variants of nonketotic hyperglycinemia. Mol Genet Metab 86:61–69CrossRefPubMed

Espandiari P, Zhang J, Schnackenberg LK, Miller TJ, Knapton A, Herman EH, Beger RD, Hanig JP (2008) Age-related differences in susceptibility to toxic effects of valproic acid in rats. J Appl Toxicol 28:628–637CrossRefPubMed

Gregus Z, Fekete T, Halászi É, Gyurasics Á, Klaassen CD (1998) Effects of fibrates on the glycine conjugation of benzoic acid in rats. Drug Metab Dispos 26:1082–1088PubMed

Guo Y, Hu C, He X, Qiu F, Zhao L (2012) Effects of UGT1A6, UGT2B7, and CYP2C9 genotypes on plasma concentrations of valproic acid in Chinese children with epilepsy. Drug Metab Pharmacokinet 27:536–542CrossRefPubMed

Hamosh A, Mcdonald JW, Valle D, Francomano CA, Niedermeyer E, Johnston MV (1992) Dextromethorphan and high-dose benzoate therapy for nonketotic hyperglycinemia in an infant. J Pediatr 121:131–135CrossRefPubMed

Hamosh A, Maher JF, Bellus GA, Rasmussen SA, Johnston MV (1998) Long-term use of high-dose benzoate and dextromethorphan for the treatment of nonketotic hyperglycinemia. J Pediatr 132:709–713CrossRefPubMed

Hauser E, Seidl R, Freilinger M, Male C, Herkner K (1996) Hematologic manifestations and impaired liver synthetic function during valproate monotherapy. Brain Dev 18:105–109CrossRefPubMed

Hejtmancik J. F. Congenital cataracts and their molecular genetics. Semin Cell Dev Biol, 2008. Elsevier, 134–149

Hennermann JB (2006) Clinical variability in glycine encephalopathy. Future Neurol 1:621.630CrossRef

Hennermann JB, Berger JM, Grieben U, Scharer G, Van Hove JL (2012) Prediction of long-term outcome in glycine encephalopathy: a clinical survey. J Inherit Metab Dis 35:253–261CrossRef

Hoover-Fong JE, Shah S, Van Hove JL, Applegarth D, Toone J, Hamosh A (2004) Natural history of nonketotic hyperglycinemia in 65 patients. Neurology 63:1847–1853CrossRefPubMed

Hung C-C, Ho J-L, Chang W-L, Tai JJ, Hsieh T-J, Hsieh Y-W, Liou H-H (2011) Association of genetic variants in six candidate genes with valproic acid therapy optimization. Pharmacogenomics 12:1107–1117CrossRefPubMed

Hussain S, Mordekar S, Prasad M (2013) The calm before the storm?: late onset Glycine encephalopathy masquerading as gastro-oesophageal reflux. J Neurodev Disord 2013

Karaoglu A, Vurucu S, Okutan V, Kurekci AE, Caycý T, Atay A, Akin R, Gokcay E (2009) Valporic acid: is it safe to use in epileptic pediatric patient? Pak J Med Sci July–September 25:539–544

Koenig SA, Buesing D, Longin E, Oehring R, Häussermann P, Kluger G, Lindmayer F, Hanusch R, Degen I, Kuhn H (2006) Valproic acid–induced Hepatopathy: nine new fatalities in Germany from 1994 to 2003. Epilepsia 47:2027–2031CrossRefPubMed

Kojima-Ishii K, Kure S, Ichinohe A, Shinka T, Narisawa A, Komatsuzaki S, Kanno J, Kamada F, Aoki Y, Yokoyama H (2008) Model mice for mild-form glycine encephalopathy: behavioral and biochemical characterizations and efficacy of antagonists for the glycine binding site of N-methyl D-aspartate receptor. Pediatr Res 64:228–233CrossRefPubMed

Kure S, Kato K, Dinopoulos A, Gail C, Degrauw TJ, Christodoulou J, Bzduch V, Kalmanchey R, Fekete G, Trojovsky A (2006) Comprehensive mutation analysis of GLDC, AMT, and GCSH in nonketotic hyperglycinemia. Hum Mutat 27:343–352CrossRefPubMed

Madu AE, Oliver L (2013) Non-ketotic hyperglycinaemia: case report and review of medical literature. J Matern Fetal Neonatal Med 26:537–539CrossRefPubMed

Magwebu ZE, Abdul-Rasool S, Seier JV, Chauke CG (2018) Autosomal recessive congenital cataract in captive-bred vervet monkeys (Chlorocebus aethiops). J Med Primatol 47:93–100CrossRefPubMed

Nasreddine W, Beydoun A (2008) Valproate-induced thrombocytopenia: a prospective monotherapy study. Epilepsia 49:438–445CrossRefPubMed

Neuberger JM, Schweitzer S, Rolland MO, Burghard R (2000) Effect of sodium benzoate in the treatment of atypical nonketotic hyperglycinaemia. J Inherit Metab Dis 23:22–26CrossRefPubMed

Ramirez N, Flynn JM, Casalduc F, Rodriguez S, Cornier AS, Carlo S (2012) Musculoskeletal manifestations of neonatal nonketotic hyperglycinemia. J Child Orthop 6:199–203CrossRefPubMedPubMedCentral

Randak C, Roschinger W, Rolinski B, Hadorn HB, Applegarth DA, Roscher AA (2000) Three siblings with nonketotic hyperglycinaemia, mildly elevated plasma homocysteine concentrations and moderate methylmalonic aciduria. J Inherit Metab Dis 23:520–522CrossRefPubMed

Roy D, Al-Asmari A, Ghazal Y, Al-Oqiel S (2003) Nonketotic hyperglycinemia in Suleimaniah Children's hospital, Riyadh, Saudi Arabia. Ann Saudi Med 24:378–381CrossRef

Star K., Edwards I. R.. Choonara I. (2014). Valproic acid and fatalities in children: a review of individual case safety reports in VigiBase

Van Hove JL, Vande Kerckhove K, Hennermann JB, Mahieu V, Declercq P, Mertens S, De Becker M, Kishnani PS, Jaeken J (2005) Benzoate treatment and the glycine index in nonketotic hyperglycinaemia. J Inherit Metab Dis 28:651–663CrossRefPubMed

Viljoen J, Bergh JJ, Mienie LJ, Kotze HF, Terre’blanche G (2012) Paracetamol prevents hyperglycinemia in vervet monkeys treated with valproate. Metab Brain Dis 27:327–335CrossRefPubMed

Titel: The effect of hyperglycinemic treatment in captive-bred Vervet monkeys (Chlorocebus aethiops)
verfasst von: Zandisiwe E. Magwebu
Mikateko Mazinu
Sahar Abdul-Rasool
Chesa G. Chauke
Publikationsdatum: 22.06.2019
Verlag: Springer US
Erschienen in: Metabolic Brain Disease / Ausgabe 5/2019
Print ISSN: 0885-7490
Elektronische ISSN: 1573-7365
DOI: https://doi.org/10.1007/s11011-019-00449-6

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

25.04.2024 | Hypotonie | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

The effect of hyperglycinemic treatment in captive-bred Vervet monkeys (Chlorocebus aethiops)

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Neurologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2019

Intrahippocampal miR-342-3p inhibition reduces β-amyloid plaques and ameliorates learning and memory in Alzheimer’s disease

Genetic testing of Mucopolysaccharidoses disease using multiplex PCR- based panels of STR markers: in silico analysis of novel mutations

Down-regulation of ERMN expression in relapsing remitting multiple sclerosis

Expression analysis of vitamin D receptor-associated lncRNAs in epileptic patients

Allicin ameliorates obesity comorbid depressive-like behaviors: involvement of the oxidative stress, mitochondrial function, autophagy, insulin resistance and NOX/Nrf2 imbalance in mice

Modulating effects of preconditioning exercise in the expression of ET-1 and BNP via HIF-1α in ischemically injured brain

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Neurologie